正在迅速成長的杭州多禧生物科技有限公司位于中國的“天堂”城市杭州。公司由五位在美國生物制藥界分別有二十多年經驗的海歸科學家創立，致力于研發新一代被譽為“生物”的抗體-藥物共軛體（ADC）抗癌藥物，志在挽救成千上萬癌癥患者的生命。我們團隊成員曾作為技術骨干為當今治療乳腺癌最有效的ADC藥物Kadcyla的成功上市做出重要貢獻。擁有數項自主知識產權的多禧生物正在迅速成為本領域的全球領跑者之一，現在加盟本公司恰逢其時。如果您是有活力的、夢想成功的專業人士，杭州多禧生物科技有限公司將為您提供一片發現、應用和發展才能的沃土。 Hangzhou DAC Biotech Co.，Ltd. is a rapidly growing start-up located in the “paradise” city of China. As a biotech company established by five oversea returnee scientists who each had more than 20 years of experience in the US pharmaceutical industry respectively, we focus on developing next generation antibody-drug conjugates (ADC) or so-called “biological missiles” for cancer treatment. The goal is to develop a technology to save hundreds and thousands of cancer patients’ lives. As key scientists in a pioneering ADC company previously, our team members had made crucial contributions to the success of Kadcyla, an ADC that is currently the most efficacious drug for the treatment of breast cancer. With several proprietary technologies and related patents in hand, our company is quickly becoming one of the global leaders in the development of ADC platform technology. It is an exciting time to work at Hangzhou DAC Biotech. If you are a dynamic, success-driven professional, our company is the place where you can identify, utilize and develop your talents. 公司優勢 1. 員工享有股權激勵和其他福利、保險、帶薪休假、年度體檢、和午餐補貼等； 2. 公司關心員工的前程，并將大力培育員工的成長； 3. 公司尊重員工，并將為員工提供各方面的權益保護； 4. 對于員工所作出的突出貢獻，公司也將格外突出地獎勵； 5. 公司會為員工準備不定期的驚喜。 簡歷投放：email: 或：浙江杭州市錢塘區下沙街道喬新路369號，郵編310018